Skip to main content
Clinical Trials/JPRN-UMIN000004569
JPRN-UMIN000004569
Completed
Phase 4

Study of assessment for vascular endothelial function and renal function with irbesartan or amlodipine in hypertensive patients with proteinuria - prospective randomized controlled trial - - Study of assessment for vascular endothelial function and renal function with irbesartan or amlodipine in hypertensive patients with proteinuria - prospective randomized controlled trial

Hokkaido University Hospital0 sites40 target enrollmentNovember 16, 2010

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Hypertension with proteinuria
Sponsor
Hokkaido University Hospital
Enrollment
40
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
November 16, 2010
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • 1\) history of anaphylaxis of irbesartan or amlodipine, 2\) patients who did not receive an antihypertensive treatment with angiotensin II receptor blockers (ARB), angiotensin converting enzyme (ACE) inhibitors or rennin inhibitor before the enrollment, 3\) secondary hypertension, 4\) history of stroke, myocardial infarction or cardiovascular disease, 5\) nephrosis, 6\) genetic renal disease, 7\) patients with nephritis treated by corticosteroids, 8\) hepatic dysfunction, 9\) moderate heart failure (New York heart Association classes II or more), 10\) patients with cancer or severe disease, 11\) uncontrolled diabetic mellitus (HbA1c 8\.0% or more), 12\) bronchial asthma, 13\) pregnancy, 14\) patients who are inadequate to enter this study due to the other reasons by physician's judgments

Outcomes

Primary Outcomes

Not specified

Similar Trials